Skip to content
OpenCapital
Get started

IQVIA IQV Equity Method Investments

Equity Method Investments at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
$3.5B+2.9%
Labcorp Holdings logo
Labcorp HoldingsLH
$146.6M-12.7%
Cognizant logo
CognizantCTSH
$113M+20.2%
Accenture logo
AccentureACN
$925.32M+55.9%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$81.68M-13.3%
Clarivate logo
ClarivateCLVT
$143.9M+252%

Other financials

Income statement

See full
Revenue$4.2B+8.4%
Gross profit$1.4B+4.4%
Operating income$514.0M+3.6%
Net income$274.0M+10.0%
EPS (diluted)$1.61+15.0%

Balance sheet

See full
Cash & equivalents$1.9B+11.9%
Total debt$16.1B+10.7%
Total equity$6.2B+4.1%
Total assets$29.7B+8.6%

Cash flow

See full
Operating cash flow$618.0M+8.8%
CapEx$127.0M-10.6%
Free cash flow$491.0M+15.3%

Valuation

See full
Market cap$32.25B+26.3%
Enterprise value$46.37B+18.6%
P/E23.3×+2.6×
P/S1.9×+0.3×

Profitability

See full
Gross margin33%-1.7pp
Operating margin13.2%-0.9pp
Net margin8.3%-0.3pp
FCF margin12.7%-1.2pp

Returns & leverage

See full
Return on equity22.7%+1.1pp
Debt / equity2.6×+0.2×
Current ratio0.7×-0.1×

Where this comes from

Reported directly by IQVIA in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: IQVIA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IQVIA's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IQVIA's equity method investments?
IQVIA (IQV) reported equity method investments of $357M in Q1 2026.
How has IQVIA's equity method investments changed year-over-year?
IQVIA's equity method investments increased by 41.1% year-over-year, from $253M to $357M.
What is the long-term trend for IQVIA's equity method investments?
Over 5 years (2020 to 2025), IQVIA's equity method investments has grown at a 31.0% compound annual growth rate (CAGR), from $84M to $324M.
What does equity method investments mean?
Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.